About Seraxis
Over a decade of pioneering science
Seraxis is a private biotechnology company launched in 2013 and located in Germantown, Maryland. The Seraxis mission is to develop a practical and potent cell replacement therapy for insulin-dependent diabetes. Our team of scientists have developed a novel cell and immune-evasion technologies that, together, reverse diabetes in animal models.
We have the vision and expertise to set T1D patients free.
We achieve our goals by
Adherence to the highest safety standards
Focusing on a scalable approach to provide relief to millions
Designing and performing every step in-house, from manufacturing through QC, to fill-and-finish and delivery to point of care
Making countless iterative improvements along the way
Working at Seraxis.
We don't have positions open at the moment. Please check back.
Partnerships
Seraxis is interested in pursuing strategic partnerships with organizations interested in bringing novel therapies to patients. Seraxis invites proposals of scientific collaborations and licensing opportunities around its technologies, across geographies and indications.
Careers
We are a rapidly growing regenerative medicine company focused on a replacement cell therapy for insulin-dependent diabetes. Dedicated professionals who are excited to join the team that overcomes all challenges in a rewarding environment are invited to apply.
Publications
Stay up-to-date with the latest thought leadership on regenerative medicine technologies, including pancreatic islet replacement therapy.
